Fuji Pharma Co., Ltd.

$14.05

$0.16(-1.15%)

Fuji Pharma Co., Ltd.

4554.T

$14.05

$0.16(-1.15%)

Fuji Pharma Co., Ltd.

4554.T

JPX

$14.05

$0.16(-1.15%)

Chart

Upcoming Earnings

Next report date

May 12, 2026

Report period

Q2 2026

EPS Estimate

—

Revenue Estimate

$84.81M

Key stats

52-Week Range$14.05

$7.38

$15.31

Market capitalization

$338.34M

Dividend yield (indicated)

1.93%

Price to earnings Ratio (TTM)

24.66

Basic EPS (TTM)

$0.60

Net income (TTM)

$14.60M

Revenue (TTM)

$341.49M

Avg. volume

167.50K

Beta (1Y)

0.37

Employees

1.66K

Market capitalization

$338.34M

Dividend yield (indicated)

1.93%

Price to earnings Ratio (TTM)

24.66

Basic EPS (TTM)

$0.60

Net income (TTM)

$14.60M

Revenue (TTM)

$341.49M

Avg. volume

167.50K

Beta (1Y)

0.37

Employees

1.66K

Screener Quick Check

About Fuji Pharma Co., Ltd.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Shuhei Morita

Website

www.fujipharma.jp

Headquarters

5-7 Sanban-cho, Tokyo, 102-0075

IPO Date

2010-02-22

Identifiers

ISINJP3816200004

Description

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products...

Related Stocks

YAKUODO HOLDINGS Co., Ltd.

7679.T

$1,976.00Mkt Cap: $38.44B

Healthcare

Medical - Pharmaceuticals

ISIN:JP3931410009

3-D Matrix, Ltd.

7777.T

$2.90Mkt Cap: $348.27M

Healthcare

Medical - Devices

ISIN:JP3410730000

Dividend Overview

Dividend yield (indicated)

1.93%

Dividend per share

$0.28annual

Payout ratio (Earnings)

44.4%

Payout ratio (FCF)

29.1%

Dividend growth streak

Dividend CAGR (3Y)

-17.2%

Dividend CAGR (5Y)

-6.3%

Dividend CAGR (10Y)

-7.3%

Dividend yield (indicated)

1.93%

Dividend per share

$0.28annual

Payout ratio (Earnings)

44.4%

Payout ratio (FCF)

29.1%

Dividend growth streak

Dividend CAGR (3Y)

-17.2%

Dividend CAGR (5Y)

-6.3%

Dividend CAGR (10Y)

-7.3%

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate